143 related articles for article (PubMed ID: 10365818)
1. Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Gadano AC; Sogni P; Heller J; Moreau R; Bories PN; Lebrec D
J Hepatol; 1999 May; 30(5):896-903. PubMed ID: 10365818
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
3. Abnormal regulation of aortic NOS2 and NOS3 activity and expression from portal vein-stenosed rats after lipopolysaccharide administration.
Heller J; Sogni P; Tazi KA; Chagneau C; Poirel O; Moreau R; Lebrec D
Hepatology; 1999 Sep; 30(3):698-704. PubMed ID: 10462376
[TBL] [Abstract][Full Text] [Related]
4. Endothelial calcium-calmodulin dependent nitric oxide synthase in the in vitro vascular hyporeactivity of portal hypertensive rats.
Gadano AC; Sogni P; Yang S; Cailmail S; Moreau R; Nepveux P; Couturier D; Lebrec D
J Hepatol; 1997 Mar; 26(3):678-86. PubMed ID: 9075677
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide in hyporeactivity to noradrenaline of isolated aortic rings in portal hypertensive rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1995 Jan; 273(1-2):167-74. PubMed ID: 7537679
[TBL] [Abstract][Full Text] [Related]
6. Cardiac impairment and nitric oxide synthase activity in the chronic portal vein-stenosed rat.
Battarbee HD; Zavecz JH; Grisham MB; Maloney RE; Chandler LJ; Mercer JW; Cady FM
Am J Physiol; 1999 Feb; 276(2):G363-72. PubMed ID: 9950809
[TBL] [Abstract][Full Text] [Related]
7. Role of aortic nitric oxide synthase 3 (eNOS) in the systemic vasodilation of portal hypertension.
Pateron D; Tazi KA; Sogni P; Heller J; Chagneau C; Poirel O; Philippe M; Moreau R; Lebrec D
Gastroenterology; 2000 Jul; 119(1):196-200. PubMed ID: 10889169
[TBL] [Abstract][Full Text] [Related]
8. The role of nitric oxide in the reduction of protein kinase C-induced contractile response in aortae from rats with portal hypertension.
Chagneau C; Tazi KA; Heller J; Sogni P; Poirel O; Moreau R; Lebrec D
J Hepatol; 2000 Jul; 33(1):26-32. PubMed ID: 10905582
[TBL] [Abstract][Full Text] [Related]
9. The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
J Hepatol; 1995 Sep; 23(3):341-7. PubMed ID: 8550999
[TBL] [Abstract][Full Text] [Related]
10. Role of shear stress in aortic eNOS up-regulation in rats with biliary cirrhosis.
Tazi KA; Barrière E; Moreau R; Heller J; Sogni P; Pateron D; Poirel O; Lebrec D
Gastroenterology; 2002 Jun; 122(7):1869-77. PubMed ID: 12055594
[TBL] [Abstract][Full Text] [Related]
11. Dose-dependent effects of a nitric oxide biosynthesis inhibitor on hyperdynamic circulation in two models of portal hypertension in conscious rats.
Pilette C; Kirstetter P; Sogni P; Cailmail S; Moreau R; Lebrec D
J Gastroenterol Hepatol; 1996 Jan; 11(1):1-6. PubMed ID: 8672735
[TBL] [Abstract][Full Text] [Related]
12. Vascular contractile response and signal transduction in endothelium-denuded aorta from cirrhotic rats.
Lin HC; Yang YY; Huang YT; Lee TY; Hou MC; Lee FY; Lee SD
World J Gastroenterol; 2005 Apr; 11(15):2306-12. PubMed ID: 15818743
[TBL] [Abstract][Full Text] [Related]
13. Relationship between protein kinase C alterations and nitric oxide overproduction in cirrhotic rat aortas.
Tazi KA; Barrière E; Moreau R; Poirel O; Lebrec D
Liver; 2002 Apr; 22(2):178-83. PubMed ID: 12028414
[TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine corrects hyperdynamic circulation without ameliorating portal hypertension and portal hypertensive gastropathy in anesthetized portal hypertensive rats.
Lee FY; Wang SS; Tsai YT; Lin HJ; Lin HC; Chu CJ; Wu SL; Tai CC; Lee SD
J Hepatol; 1997 Mar; 26(3):687-93. PubMed ID: 9075678
[TBL] [Abstract][Full Text] [Related]
15. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
16. Induction of nitric oxide synthase II does not account for excess vascular nitric oxide production in experimental cirrhosis.
Sogni P; Smith AP; Gadano A; Lebrec D; Higenbottam TW
J Hepatol; 1997 May; 26(5):1120-7. PubMed ID: 9186843
[TBL] [Abstract][Full Text] [Related]
17. iNOS expression in vascular resident macrophages contributes to circulatory dysfunction of splanchnic vascular smooth muscle contractions in portal hypertensive rats.
Kajita M; Murata T; Horiguchi K; Iizuka M; Hori M; Ozaki H
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H1021-31. PubMed ID: 21193589
[TBL] [Abstract][Full Text] [Related]
18. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
[TBL] [Abstract][Full Text] [Related]
19. Use of arginine analogs as inhibitors of nitric oxide synthase in rat-aortic rings.
Russell RJ
Methods Mol Biol; 1998; 100():243-50. PubMed ID: 10907010
[No Abstract] [Full Text] [Related]
20. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension.
Bomzon A; Jacob G; Lee SS; Meddings J
Clin Invest Med; 1991 Feb; 14(1):63-71. PubMed ID: 2040106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
